The Asia-Pacific Scar treatment market has been estimated at USD 3.45 billion in 2018 and is projected to reach USD 5.43 billion by 2023, at a CAGR of 11.05% during the forecast period from 2016 to 2021. Growth of Scar treatment market in the Asia-Pacific region is higher than the developed regions, the reason being improving healthcare facilities and increase in population.
Treatment of scars can never remove scars permanently but can reduce their appearance and make them less visible. To make the existing treatment more effective and efficient, a lot of research is required. Treatments like laser procedures involve side effects which need consideration and advancement.
The market is witnessing substantial growth due to rising incidence of skin related diseases among all age groups and rise in expenditure on personal care. However, the market growth is hindered owing to side effects associated with the treatment and also high costs of advanced scar treatment procedures.
The Asia-Pacific scar treatment market is mainly segmented based on type of treatment into Topical treatment, Surface Treatment, Laser Treatment, Injectable Treatment and Invasive Surgical Treatment. Topical treatment is further segmented into creams, oils, gels and gel sheets. Surface treatment can be sub segmented into Dermabrasion, Chemical Peeling and Cryosurgery. Injectable treatment can be divided into tissue fillers and steroid injections. Based on scar type the market is bifurcated into Keloid and Hypertrophic Scars, Contracture Scars, Acne scars, Stretch scars and post-surgical scars. Basis on end users the market is segmented into hospitals, private clinics, pharmacies & drug stores and E-Commerce. Acne scars are the most common; their treatment involves antibiotic treatment or laser solutions. Based on geography the Asia-Pacific Market is segmented and analysed under the countries like India, China, Japan, Australia and South Korea.
Major players dominating the scar treatment market are Occulus Innovative Sciences Inc., Smith & Nephew PLC, Nutramarks Inc., Merz Inc., Enaltus LLC, CCA Industries Inc., Cynosure IncLumenis, Syneron Medical Ltd., Mölnlycke Health Care, Avita Medical Limited, Pacific World Corporation, Shanghai Fosun Pharmaceuticals Ltd. (AC. Alma Lasers), Valeant Pharmaceuticals International Inc., and Beijing Toplaser Technology Company Limited.
1. Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 New Developments
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 By Treatment Type
5.1.1 Topical Treatment
5.1.1.1 Creams
5.1.1.2 Oils
5.1.1.3 Gels
5.1.1.4 Gel Sheets
5.1.2 Surface Treatment
5.1.2.1 Dermabrasion
5.1.2.2 Chemical Peeling
5.1.2.3 Cryosurgery
5.1.3 Laser Treatment
5.1.4 Injectable Treatment
5.1.4.1 Tissue Fillers
5.1.4.2 Steroid Injections
5.1.5 Invasive Surgical Treatment
5.2 By Scar Type
5.2.1 Keloid and Hypertrophic Scars
5.2.2 Contracture Scars
5.2.3 Acne Scars
5.2.4 Stretch Scars
5.2.5 Post-Surgical Scars
5.3 By End Users
5.3.1 Hospitals
5.3.2 Private Clinics
5.3.3 Pharmacies & Drug Stores
5.3.4 E-Commerce
6. Geographical Analysis
6.3 Asia-Pacific
6.1 Introduction
6.2 China
6.3 India
6.4 Japan
6.5 South Korea
6.6 Australia
7. Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8. Market Leaders' Analysis
8.1 Occulus Innovative Sciences Inc.
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Strategic Evaluation and Operations
8.1.4 Financial analysis
8.1.5 Legal issues
8.1.6 Recent Developments
8.1.7 SWOT analysis
8.1.8 Analyst View
8.2 Smith & Nephew PLC
8.3 Nutramarks Inc.
8.4 Merz Inc.
8.5 Enaltus LLC
8.6 CCA Industries Inc.
8.7 Cynosure IncLumenis
8.8 Syneron Medical Ltd.
8.9 Syneron Medical Ltd.
8.10 Avita Medical Limited
8.11 Pacific World Corporation
8.12 Shanghai Fosun Pharmaceuticals Ltd.
9. Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10. Expert Opinions
10.1 Market Outlook
10.2 Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
